Texas Biomedical Research Institute Secures $23 Million Grant for Cutting-Edge Research Initiatives

Texas Biomedical Research Institute (Texas Biomed), a premier independent biomedical research institution located in San Antonio, Texas, is thrilled to announce the successful raising of $23 million in funding to further its mission of advancing health worldwide through innovative biomedical research. This significant investment will empower Texas Biomed to expand its already extensive research efforts across a variety of critical health issues, including cardiovascular diseases, psychiatric disorders, and infectious diseases such as Tuberculosis and Ebolavirus. The funding will support over 200 major research projects led by its team of more than 300 dedicated scientists and will also contribute to the operational advancements of its cutting-edge facilities, including the nation’s only privately-owned BSL-4 laboratory and the renowned AT&T Genomics Computing Center. As the largest biomedical research institute of its kind, Texas Biomed plays an essential role as a hub for both local and global health initiatives. This funding aims to not only enhance its existing research capacities but also to foster partnerships with other leading institutions, further accelerating the pace of discovery and innovation. With a mission grounded in combating some of the most pressing health challenges, this new capital injection positions Texas Biomed to remain at the forefront of biomedical research and health advancements for years to come. For more information about the groundbreaking work at Texas Biomed, please visit www.TxBiomed.org.